A clinical trial evaluating use of moroctocog alfa (AF-CC) in children less than 6 years of age is on going.
Praegu toimub kliiniline uuring moroktokog alfa (AF- CC) kasutamise hindamiseks alla 6 aasta vanustel lastel.